Published in Transplantation on June 27, 2004
Complications of right lobe living donor liver transplantation. J Hepatol (2009) 1.73
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant (2008) 1.69
Biliary reconstruction in right lobe living-donor liver transplantation: Comparison of different techniques in 321 recipients. Ann Surg (2006) 1.35
Endoscopic management of biliary strictures after liver transplantation. World J Gastroenterol (2009) 1.11
Liver transplantation in Indian Armed Forces-initial experience. Med J Armed Forces India (2012) 1.01
Biliary complications after a right-lobe living donor liver transplantation. J Gastroenterol (2005) 0.99
Operative outcomes of adult-to-adult right lobe live donor liver transplantation: a comparative study with cadaveric whole-graft liver transplantation in a single center. Ann Surg (2006) 0.99
Biliary complications following orthotopic liver transplantation: a 10-year audit. HPB (Oxford) (2011) 0.99
Liver transplantation: fifty years of experience. World J Gastroenterol (2014) 0.98
Biliary Stricture after Adult Right-Lobe Living-Donor Liver Transplantation with Duct-to-Duct Anastomosis: Long-Term Outcome and Its Related Factors after Endoscopic Treatment. Gut Liver (2010) 0.91
Adult-to-adult living donor liver transplantation. Can J Gastroenterol (2006) 0.90
Salvage liver transplantation in the treatment of hepatocellular carcinoma: a meta-analysis. World J Gastroenterol (2012) 0.90
Indications and contraindications for liver transplantation. Int J Hepatol (2011) 0.88
Biliary complications in liver transplantation. Hepatol Int (2008) 0.87
Biliary reconstruction and complications after living-donor liver transplantation. HPB (Oxford) (2009) 0.85
Interventional radiology procedures in adult patients who underwent liver transplantation. World J Gastroenterol (2009) 0.84
Management of biliary complications following living donor liver transplantation--a single center experience. Langenbecks Arch Surg (2009) 0.84
Biliary complications after right lobe living donor liver transplantation: a single-centre experience. HPB (Oxford) (2011) 0.84
Donor safety in live-related liver transplantation. Indian J Surg (2011) 0.82
Current diagnosis and treatment of benign biliary strictures after living donor liver transplantation. World J Gastroenterol (2016) 0.81
Endoscopic management of post-liver transplant biliary complications. World J Gastrointest Endosc (2015) 0.80
Advances in endoscopic management of biliary complications after living donor liver transplantation: Comprehensive review of the literature. World J Gastroenterol (2016) 0.78
Management of Biliary Strictures After Liver Transplantation. Gastroenterol Hepatol (N Y) (2015) 0.78
Bile duct reconstruction by a young surgeon in living donor liver transplantation using right liver graft. Medicine (Baltimore) (2014) 0.78
Interventional radiology in living donor liver transplant. World J Gastroenterol (2014) 0.78
Post-liver Transplant Biliary Complications. J Clin Exp Hepatol (2012) 0.78
Adult to adult living related liver transplantation: where do we currently stand? World J Gastroenterol (2012) 0.77
Spectrum of biliary complications following live donor liver transplantation. World J Hepatol (2015) 0.77
The Preliminary Study on Procurement Biliary Convergence from Donors with Complicated Bile Duct Variant in Emergency Right Lobe Living Donor Liver Transplantation. J Clin Exp Hepatol (2016) 0.75
Risk factors of biliary intervention by imaging after living donor liver transplantation. World J Gastroenterol (2016) 0.75
Management issues in post living donor liver transplant biliary strictures. World J Hepatol (2016) 0.75
Endoscopic management of bile leakage after liver transplantation. Gut Liver (2015) 0.75
Percutaneous transhepatic techniques for management of biliary anastomotic strictures in living donor liver transplant recipients. Indian J Radiol Imaging (2017) 0.75
Duct-to-duct biliary reconstruction during complex hepatectomy: a useful technique in selected cases. World J Surg (2012) 0.75
Endoscopic management of biliary strictures after living donor liver transplantation. Clin J Gastroenterol (2017) 0.75
Endoscopic therapy for biliary strictures complicating living donor liver transplantation: Factors predicting better outcome. World J Gastrointest Pathophysiol (2017) 0.75
Radiopaque biodegradable stent for duct-to-duct biliary reconstruction in pigs. Langenbecks Arch Surg (2016) 0.75
Biliary complications after living donor liver transplantation: A retrospective analysis of the Kyoto experience 1999-2004. Indian J Gastroenterol (2017) 0.75
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology (2011) 2.66
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl (2010) 2.57
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology (2013) 2.42
Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg (2002) 2.14
The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. Ann Surg Oncol (2005) 2.13
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: a 5-year experience. Liver Transpl (2015) 2.03
Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg (2003) 2.03
A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology (2009) 1.90
Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl (2004) 1.88
Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res (2010) 1.79
The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl (2008) 1.75
Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg (2012) 1.70
Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med (2013) 1.63
Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy. Liver Transpl (2008) 1.61
Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol (2006) 1.59
Prediction of intraoperative transfusion requirements during orthotopic liver transplantation and the influence on postoperative patient survival. Anesth Analg (2014) 1.52
Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol (2008) 1.50
Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol (2007) 1.49
Modified multivisceral transplantation with splenopancreatic preservation. Transplantation (2007) 1.49
Safety and effectiveness of renoportal bypass in patients with complete portal vein thrombosis: an analysis of 10 patients. Liver Transpl (2015) 1.49
Portal hypertension in children: expert pediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension. Pediatr Transplant (2012) 1.49
Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma. Ann Surg Oncol (2005) 1.48
Comparable graft and patient survival in lean and obese liver transplant recipients. Liver Transpl (2013) 1.47
Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch Bronconeumol (2013) 1.47
Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas. Liver Int (2010) 1.46
Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology (2005) 1.44
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. Transplantation (2006) 1.43
Authors' Submission Toolkit: a practical guide to getting your research published. Curr Med Res Opin (2010) 1.39
Living donor kidney transplantation: medical, legal, and ethical considerations. South Med J (2007) 1.39
Utility of azathioprine metabolite measurements in post-transplant recurrent autoimmune and immune-mediated hepatitis. Pediatr Transplant (2004) 1.39
Three-dimensional print of a liver for preoperative planning in living donor liver transplantation. Liver Transpl (2013) 1.39
Characteristics of human calicivirus enteritis in intestinal transplant recipients. J Pediatr Gastroenterol Nutr (2005) 1.37
Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg (2004) 1.36
Anatomic variations in right liver living donors. J Am Coll Surg (2004) 1.33
Observing terrestrial ecosystems and the carbon cycle from space. Glob Chang Biol (2015) 1.26
Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol (2008) 1.26
Pregnancy outcome in liver transplant recipients. Obstet Gynecol (2003) 1.23
Impact of biliary complications in right lobe living donor liver transplantation. Transpl Int (2006) 1.23
Living donor liver transplantation: summary of a conference at The National Institutes of Health. Liver Transpl (2002) 1.22
Toxic waste disposal in Escherichia coli. J Bacteriol (2002) 1.17
Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease. Clin Transplant (2004) 1.17
Quality of life after lobectomy for adult liver transplantation. Transplantation (2002) 1.15
[Use of a coronary risk score (the TIMI Risk Score) in a non-selected patient population assessed for chest pain at an emergency department]. Rev Esp Cardiol (2005) 1.13
Clinical case of the month. Heterotopic pancreas. J La State Med Soc (2011) 1.11
Liver and intestine transplantation: summary analysis, 1994-2003. Am J Transplant (2005) 1.09
Calicivirus enteritis in an intestinal transplant recipient. Am J Transplant (2003) 1.08
Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis. J Biol Chem (2013) 1.07
Perioperative blood transfusion and long-term outcomes after resection of hilar cholangiocarcinoma. J Gastrointest Surg (2015) 1.07
Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery (2007) 1.07
Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome. Clin J Am Soc Nephrol (2008) 1.06
Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol (2012) 1.06
Surgical therapy for hepatolithiasis: a Western experience. J Am Coll Surg (2005) 1.03
Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection. J Hepatobiliary Pancreat Surg (2002) 1.03
Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg (2002) 1.03
Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg (2008) 1.02
Isolated intestinal transplantation: proof of clinical efficacy. Transplantation (2003) 1.00
Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Ann Surg (2014) 0.99
Incentives for organ donation: proposed standards for an internationally acceptable system. Am J Transplant (2011) 0.99
Laparoscopic versus open resection of colorectal liver metastasis. Surg Endosc (2012) 0.98
Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinoma. Am Surg (2010) 0.98
Metals content in placentas from moderate cigarette consumers: correlation with newborn birth weight. Biometals (2005) 0.97
[Geographical variations in the prevalence of COPD in Spain: relationship to smoking, death rates and other determining factors]. Arch Bronconeumol (2010) 0.96
Outcome of hepatic artery reconstruction in liver transplantation with an iliac arterial interposition graft. Clin Transplant (2005) 0.96
Recommendations for the Critical Care Management of Devastating Brain Injury: Prognostication, Psychosocial, and Ethical Management : A Position Statement for Healthcare Professionals from the Neurocritical Care Society. Neurocrit Care (2015) 0.94
Evaluation of polycyclic aromatic hydrocarbons using analytical methods, toxicology, and risk assessment research: seafood safety after a petroleum spill as an example. Environ Health Perspect (2013) 0.94
Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg (2002) 0.94
Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation. Clin Transplant (2010) 0.93
Liver transplantation for neuroendocrine tumors. J Gastrointest Surg (2004) 0.93
Calicivirus infection in pediatric small intestine transplant recipients: pathological considerations. Hum Pathol (2004) 0.93
Is there an advantage of living over deceased donation in liver transplantation? Transpl Int (2012) 0.93
High body mass index and short- and long-term renal allograft survival in adults. Transplantation (2005) 0.92
Ocean fertilization: time to move on. Nature (2009) 0.91
Post-traumatic pseudoaneurysm of the common hepatic artery with duodenal fistula. HPB (Oxford) (2002) 0.91
Parenteral nutrition associated liver disease. Semin Neonatol (2003) 0.91
Spirometrically-defined restrictive ventilatory defect: population variability and individual determinants. Prim Care Respir J (2012) 0.91
Early and frequent histological recurrence of Crohn's disease in small intestinal allografts. Transplantation (2005) 0.91
Hepatitis C in children: a quaternary referral center perspective. J Pediatr Gastroenterol Nutr (2006) 0.90
Isolated left ventricular apical hypoplasia. Rev Esp Cardiol (2010) 0.90
Venous outflow reconstructions with the piggyback technique in liver transplantation: a single-center experience of 431 cases. Transpl Int (2005) 0.90
Donor-recipient gender and size mismatch affects graft success after kidney transplantation. J Am Coll Surg (2010) 0.90
Resection of large hepatocellular carcinoma (≥10 cm): a unique western perspective. J Surg Oncol (2012) 0.90
Pulmonary hypertension after liver transplantation in patients with antecedent hepatopulmonary syndrome: a report of 2 cases and review of the literature. Liver Transpl (2006) 0.89
Highly immunostimulatory RNA derived from a Sendai virus defective viral genome. Vaccine (2013) 0.89
Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation. Hepatology (2015) 0.88
The incidence and significance of late acute cellular rejection (>1000 days) after liver transplantation. Clin Transplant (2004) 0.88